Today's Veterinary Practice

NOV-DEC 2015

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: http://todaysveterinarypractice.epubxp.com/i/591321

Contents of this Issue

Navigation

Page 39 of 107

VETORYL is a trademark of Dechra LTD. ©2015, Dechra Ltd. NADA 141-291, Approved by FDA CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In feld studies and post-approval experience, the most common side effects reported were: anorexia, lethargy/ depression, vomiting, diarrhea, elevated liver enzymes, elevated potassium with or without elevated sodium, elevated BUN, decreased Na/K ratio, hypoadrenocorticism, weakness, elevated creatinine, shaking, and renal insuffciency. In some cases, death has been reported as an outcome of these adverse events. VETORYL Capsules are not for use in dogs with primary hepatic or renal disease, or in pregnant dogs. Refer to the prescribing information for complete details or visit www.Dechra-US.com. Dechra Veterinary Products US and the Dechra D logo are registered trademarks of Dechra Pharmaceuticals PLC. VETORYL ® CAPSULES (trilostane) are the only FDA veterinary- approved treatment for pituitary-dependent and adrenal-dependent hyperadrenocorticism. When you choose VETORYL Capsules 5mg strength to treat your small patients, you can be confdent you're not taking any unnecessary risks associated with compounded trilostane. VETORYL Capsules 5mg strength gives you the ability to offer medication to your clients and patients with a proven safety and effcacy profle and consistent quality. VETORYL Capsules are available in strengths for all sizes of dogs: 5mg, 10mg, 30mg, 60mg and 120mg. Contact your veterinary distributor to learn about the current promotion on VETORYL Capsules. They may be small, but their treatment is now mighty. VETORYL ® Capsules (trilostane) are now available in a 5mg strength. "Trilostane content of compounded capsules may vary from the prescribed strength, and dissolution characteristics may not match those of the licensed product. The use of compounded trilostane products may therefore negatively impact the management of dogs with hyperadrenocorticism." 1 1 Pharmaceutical Evaluation of Compounded Trilostane Products (Cook, et al, JAAHA 48:4, Jul/Aug 2012)

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - NOV-DEC 2015